Please login to the form below
economy
This page shows the latest economy news and features for those working in and with pharma, biotech and healthcare.
US to donate 500 million Pfizer/BioNTech COVID-19 vaccine doses through COVAX
The US will allocate the doses to 92 low- and lower middle-income countries and economies, as defined by Gavi’s COVAX Advance Market Commitment (AMC) and the 55 member states
Latest news
-
Responsibly growing our talent pool
Despite the devastating effect the pandemic, and perhaps Brexit, are inflicting on the economy as a whole, in healthcare communications there is still a growing need for new talent and a
-
EU considers blocking COVID-19 vaccine exports to the UK
Human lives, civil liberties and our economy are dependant on the speed of vaccination moving forward,” she added.
-
WHO agrees to no-fault compensation for rare serious side effects from COVAX-distributed vaccines
It covers all 92 low- and middle-income countries and economies that are eligible for support from the COVAX Facility until 30 June 2022. ... This no-fault compensation mechanism helps to ensure that people in AMC-eligible countries and economies can
-
The World Bank is working towards standardising COVID-19 vaccine contracts
the devastating impacts of the pandemic on people and economies.”.
-
Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds
vaccines. “As long as the virus remains unchecked anywhere on the planet, it will continue to mutate, breach borders and wreak havoc on communities and the global economy,” said the ONE
Responsibly growing our talent pool
EU considers blocking COVID-19 vaccine exports to the UK
WHO agrees to no-fault compensation for rare serious side effects from COVAX-distributed vaccines
The World Bank is working towards standardising COVID-19 vaccine contracts
More from news
Approximately 7 fully matching, plus 531 partially matching documents found.
Latest Intelligence
-
A new era for UK-Japanese scientific research relations
Japan’s healthcare needs. Japan’s healthcare economy has evolved immensely since WWII. ... economy. What is non-negotiable, however, when working on these trials is access to a considerable Japanese patient population.
-
Rare genetic diseases – what’s in store for 2021?
It was a tough year for many industries. Global economies have suffered, but in some areas the pandemic has also been a wake-up call, as COVID-19 has necessitated and
-
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities. It goes without saying that COVID-19 has had a tremendous impact on our global society and economy.
-
Rethinking our approach to infectious disease preparedness
But we now know that these interventions come at a huge cost to the national economy and well-being of individuals so, in the end, we need a timely supply of ... The ongoing COVID-19 pandemic has demonstrated the huge cost to our economies and healthcare
-
NICE – but not enough
Worse still, the financial impact of COVID-19 on local health economies has only increased the challenge; hard just got harder.
A new era for UK-Japanese scientific research relations
Rare genetic diseases – what’s in store for 2021?
The important role of CROs in shaping the future of clinical research across Europe
Rethinking our approach to infectious disease preparedness
NICE – but not enough
More from intelligence
Approximately 4 fully matching, plus 131 partially matching documents found.
Latest appointments
-
Doina Ionescu elected to ABPI’s board of directors
Ionescu will represent medium-sized companies on the ABPI board of directors, with aims of further strengthening the relationship between the pharma industry, patients, the NHS and the UK economy.
-
Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare
Prior to that his roles included multichannel manager, customer and field support team manager and health economy liaison manager.
-
Clinerion appoints new regional head
He said: “ Clinical trials bring many benefits to a country’s economy, to hospitals, physicians and patients.
-
ABPI Scotland appoints Sandra Auld as director
In addition, Sandra will continue to lead all initiatives to improve the environment for the pharmaceutical industry in Scotland and its role in contributing to the UK economy.”.
-
Life Science Hub Wales names COO
Economy minister for Wales Edwina Hart welcomed Dr Barwick's appointment, saying he will “play a key role in establishing a thriving ecosystem for the sector in Wales”.
Doina Ionescu elected to ABPI’s board of directors
Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare
Clinerion appoints new regional head
ABPI Scotland appoints Sandra Auld as director
Life Science Hub Wales names COO
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Remote Patient Monitoring
huge. With a patient-centric, digital-first approach, the wider health economy will gain from a huge influx of data.
-
Greener healthcare - a shared challenge
recovery. The green economy is fundamental within the UK narrative of Build Back Better – and the economic and social benefits of decarbonised and more efficient healthcare systems are critical to this. ... Analysis has suggested that combined CO2
-
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
All of this is bad for the economy and wider society.
-
Feeling the pressure?
It costs the UK economy around £5 billion per year. 1.
-
What are the changes shaping the future of health and wellbeing and who are the 'Power Consumers'
As we start to slowly emerge from lockdown, find out how the changes spotlighted in our Wellcare Economy Report are still holding true and how we need to be communicating with ... The Global Wellness Economy Monitor, 2018. Last accessed July 2019,
Greener healthcare - a shared challenge
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
What are the changes shaping the future of health and wellbeing and who are the 'Power Consumers'
More from PMHub
Approximately 1 fully matching, plus 79 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Manager
-
Salary TBC
-
Publications Director
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
-
Planner
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- FDA advisory committee overwhelmingly votes no on Biogen's aducanumab
- Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
- Servier, Oncodesign select first preclinical candidate from Parkinson’s disease collaboration
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Regeneron’s COVID-19 drug boosts survival in hospitalised patients lacking antibodies
- GSK partners with iTeos Therapeutics on next-gen immuno-oncology drug
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- Your clinical trial participants are precious, so treat them as such
- Diversity and inclusion in clinical trials
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- Nicky Hutchens appointed as deputy managing director at Four Health
- Rediscovering the human touch in healthcare
- Lucid Group acquires US-based strategic brand consultants DiD
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
- Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
- The power of communication: Engaging diverse groups in healthcare
- Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
- Building the hospital of the future
- Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
